GLP1R and medullary thyroid gland carcinoma: To sum up the GLP-1 receptor-expressing tumors, among others also MTC, are prospective candidates for in vivo targeting with Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4.